Sarepta Therapeutics | SRPT - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amgen USD 54.6B 17M 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 605.86M 1.62M 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-12
Incyte USD 39.43M 982K 2026-03
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Moderna USD 1.31B 571M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.96B 3.11B 2025-12
PTC Therapeutics USD 2.71B 2.42B 2025-12
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 2.03B 195.7M 2025-12